Abstract
Objectives: Respiratory Syncytial Virus (RSV) is the most common cause of severe respiratory illness in young children. Data on the host factors that contribute to infection of young children by RSV are limited. The human chemokine receptor, CX3CR1, has recently been implicated as an RSV receptor in adult epithelial cells in vitro. Here we evaluate a role for CX3CR1 in pediatric lung RSV infections. Study Design: CX3CR1 transcript levels were assessed in pediatric airways using existing RNAseq data characterizing gene expression in the upper and lower airways. Tissue localization and cell specific expression of CX3CR1 in pediatric lung tissue was confirmed using in situ hybridization and immunohistochemistry. The role of CX3CR1 in RSV infection was also investigated in vitro using a novel, physiological model of pediatric epithelial cells. Results: Low levels of CX3CR1 transcript were often, but not always, expressed in both the upper (62%) and lower airways (36%) of pediatric subjects between 1 month and 8 years of age. CX3CR1 transcript and protein expression was detected in epithelial cells of intact, normal human pediatric lung tissues. In vitro, CX3CR1 expression was readily detected on primary cultures of differentiated pediatric/infant human lung epithelial cells. RSV demonstrated preferential infection of CX3CR1 positive cells, and blocking CX3CR1/RSV interaction significantly decreased productive viral infection in vitro. Conclusions: CX3CR1 is present in the airways of pediatric subjects where it may serve as a receptor for RSV infection. Furthermore, CX3CR1 appears to play a mechanistic role in mediating viral infection of pediatric airway epithelial cells in vitro.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by the NIH/NIAID HHSN272201200005C, NIH/NHLB I1U01HL122700 and the University of Rochester Pulmonary training grant T32-HL066988.
Author Declarations
All relevant ethical guidelines have been followed and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
Any clinical trials involved have been registered with an ICMJE-approved registry such as ClinicalTrials.gov and the trial ID is included in the manuscript.
Not Applicable
I have followed all appropriate research reporting guidelines and uploaded the relevant Equator, ICMJE or other checklist(s) as supplementary files, if applicable.
Yes
Data Availability
All data is included within the manuscript.
